Laura Chico
Stock Analyst at Wedbush
(0)
# 4335
Out of 5,240 analysts
233
Total ratings
32.06%
Success rate
-10.27%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceu... | Reiterates: Neutral | 46 48 | 42.46 | 13.05% | 12 | Jan 13, 2025 | |
Neurocrine Bioscienc... | Reiterates: Outperform | 148 148 | 140.08 | 5.65% | 8 | Dec 16, 2024 | |
Solid Biosciences | Initiates Coverage On: Outperform | 16 | 3.14 | 409.55% | 1 | Dec 13, 2024 | |
Edgewise Therapeutic... | Maintains: Outperform | 44 45 | 28.89 | 55.76% | 9 | Nov 8, 2024 | |
Vigil Neuroscience | Maintains: Outperform | 23 24 | 1.83 | 1211.48% | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 12 | 2.75 | 336.36% | 9 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 30 38 | 35.26 | 7.77% | 7 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 4 | 4.46 | -10.31% | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 9 8 | 7.43 | 7.67% | 8 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 25 | 17.7 | 41.24% | 9 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 3.43 | 541.4% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 210 205 | 145.32 | 41.07% | 16 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 44 | n/a | n/a | 7 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 40 48 | 67.69 | -29.09% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 22 22 | 7.38 | 198.1% | 8 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 4 | 0.89 | 349.44% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 41 | 29.71 | 38% | 13 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 49 | 40.3 | 21.59% | 8 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 38 36 | 20.21 | 78.13% | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 8 7 | 5.23 | 33.84% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 26 | 20.23 | 28.52% | 7 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 11 11 | 5.59 | 96.78% | 13 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 42 42 | 16.97 | 147.5% | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 17 17 | 8.9 | 91.01% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 41 41 | 2.46 | 1566.67% | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 31 | 16.4 | 89.02% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 11 | 0.91 | 1108.79% | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 0.78 | 925.64% | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 5 | 4.1 | 21.95% | 5 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 330 | n/a | n/a | 6 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 5 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 42 | n/a | n/a | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 5 | n/a | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 5 | 1.65 | 203.03% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 149 | 36.74 | 304.19% | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | n/a | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 33 | n/a | n/a | 1 | Sep 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 40 | n/a | n/a | 3 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 240 0 | n/a | n/a | 2 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Outperform | 36 0 | n/a | n/a | 2 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Jan 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 720 | 12.21 | 5796.81% | 1 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 1 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Strong Buy | 280 | 20.13 | 1290.96% | 1 | Apr 21, 2017 |